Peelback

Publishing
research is
just the start.

Peelback turns findings into formats every audience can use, in minutes, verified by the researcher.

A health researcher at work in a laboratory
The findings

What researchers told us

Peelback is built on an Innovate UK funded project with the University of Exeter: 152 participants across six research activities, including researchers, patients, clinicians, policymakers and industry professionals.

84%

of researchers said the same finding should be told differently to a patient, a clinician or a policymaker.

73%

of researchers said a lack of time is what stops them from sharing their work more widely.

77%

of decision-makers said a researcher's sign-off is what would make them trust an AI-written summary.

Read the full findings report Open the report
Supported by
Innovate UK Creative UK Oxford Innovation University of Exeter University of Plymouth
The method

A simpler way to share research

Peelback is an AI platform for research communication. It drafts the translation, the researcher verifies it, and the person reading it gets something they can use and trust.

01

Upload

A researcher drops in their published paper. Peelback reads it and pulls out what matters: the findings, the data, the detail.

02

Translate

The same finding, rewritten for whoever is reading it. Every audience at once, starting with patients, clinicians and policymakers.

03

Verify

Nothing is shared until the researcher confirms every version is faithful to the findings. Each one carries their sign-off.

04

Share

Download it, link it, send it, from plain-language summaries to policy briefs. Ready for wherever the work needs to go.

The platform

See the same finding, three ways

Click between patient, clinician and policymaker. Same result, different reader.

Every audience at once

Reaching each audience usually means rewriting the work from scratch, once per reader. Peelback creates and formats every version together, in minutes, starting with patients, clinicians and policymakers.

Verified by the researcher

Every plain-language summary is checked and signed off by the health researcher behind the work, and carries a visible verification badge. That's what makes it safe to share, and safe to trust.

Patient Clinician Policymaker
For patients

A short daily walk lowered relapse risk by nearly a third.

People in the study who walked briskly most days were far less likely to see their condition return over the following year.

Verified by the researcher
For clinicians

Moderate aerobic activity cut 12-month relapse by 31%.

A structured walking regimen (30 min, 5x/week) was associated with a statistically significant reduction in relapse versus usual care (HR 0.69, 95% CI 0.54 to 0.88).

Verified by the researcher
For policymakers

A low-cost activity programme could reduce relapse-related admissions.

Scaling a supervised walking intervention offers a plausible, low-cost route to fewer readmissions, with implications for community care commissioning.

Verified by the researcher